Identify biomarkers of neuropsychiatric systemic lupus erythematosus by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry combined with weak cation magnetic beads

Journal of Rheumatology

Volumn 38, Issue 3, 2011, Pages 454-461

  Sun, Ling ^a   Chen, Hua ^a   Hu, Chaojun ^a   Wang, Peng ^b   Li, Yongzhe ^a   Xie, Jing ^b   Tang, Fulin ^a   Ba, Denian ^c   Zhang, Xuan ^a   He, Wei ^c  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Matrix assisted laser desorption ionization time of flight mass spectrometry; Neuropsychiatric lupus; Ubiquitin; Weak cation exchange magnetic beads

Indexed keywords

BIOLOGICAL MARKER; BIOMEDICAL AND DENTAL MATERIALS; CYCLOPHOSPHAMIDE; DEXAMETHASONE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; UBIQUITIN; UNCLASSIFIED DRUG; WEAK CATION EXCHANGE MAGNETIC BEAD;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR MODEL; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CATIONS; FEMALE; HUMANS; IMMUNOMAGNETIC SEPARATION; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; PROTEOME; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

EID: 79952388719     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100550     Document Type: Article

References (22)

1. Hanly JG. ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables. Lupus 2004;13:861-4. (Pubitemid 39555517)
2. Liang MH, Corzillius M, Bae SC, Lew RA, Fortin PR, Gordon C. The American College of Rheumatology nomenclature and case definition for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608. (Pubitemid 29171979)
3. Castellino G, Govoni M, Giacuzzo S, Trotta F. Optimizing clinical monitoring of central nervous system involvement in SLE. Autoimmun Rev 2008;7:297-304.
4. Zhang X, Dong Y, Tang FL. Central nervous system involvement in systemic lupus erythematosus. J Clin Rheumatol 1999;5:314-9.
5. Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland Lupus Cohort. Rheumatology 2004;43:1555-60. (Pubitemid 39642582)
6. Guerreiro N, Gomez-Mancilla B, Charmont S. Optimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluid. Proteome Sci 2006;4:7.
7. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
8. Dong Y, Zhang X, Tang FL, Tian XP, Zhao Y, Zhang FC. Intrathecal injection with methotrexate plus dexamethasone in the treatment of central nervous system involvement in systemic lupus erythematosus. Chin Med J 2001;114:764-6. (Pubitemid 32769521)
9. Villanueva J, Philip J, Entenberg D, Chaparro CA, Tanwar MK, Holland EC, et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 2004;76:1560-70. (Pubitemid 38338398)
10. Baumann S, Ceglarek U, Fiedler GM, Lembcke J, Leichtle A, Thiery J. Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 2005;51:973-80. (Pubitemid 40740877)
11. Breiman L, Friedman J, Stone CJ, Olshen RA. Classification and regression trees. Boca Raton: Chapman & Hall; 1984.
12. Bañez LL, Prasanna P, Sun L, Ali A, Zou Z, Adam B-L, et al. Diagnostic potential of serum proteomic patterns in prostate cancer. J Urol 2003;170(2 part 1):442-6. (Pubitemid 36870220)
13. Mei J, Kolbin D, Kao H-T, Porton B. Protein expression profiling of postmortem brain in schizophrenia. Schizophr Res 2006;84:204-13.
14. Li Y-Z, Hu C-J, Leng X-M, Zhao G-F, Li N, Xu Y. Promising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI-TOF-MS. Anat Rec 2009;292:455-60.
15. Mosley K, Tam FW, Edwards RJ, Crozier J, Pusey CD, Lightstone L. Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology 2006;45:1497-504. (Pubitemid 44817055)
16. Suzuki M, Ross GF, Wiers K, Nelson S, Bennett M, Passo MH, et al. Identification of a urinary proteomic signature for lupus nephritis in children. Pediatr Nephrol 2007;22:2047-57. (Pubitemid 350090711)
17. Rovin BH, Birmingham DJ, Nagaraja HN, Yu CY, Hebert LA. Biomarker discovery in human SLE nephritis. Bull Hosp Joint Dis 2007;65:187-93. (Pubitemid 351412131)
18. Huang ZC, Shi YY, Cai B, Wang LL, Wu YK, Ying BW. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus. Rheumatology 2009;48:626-31.
19. Hochstrasser M. Origin and function of ubiquitin-like proteins. Nature 2009;458:422-9.
20. Iqbal K, Grundke-Iqbal I. Elevated levels of tau and ubiquitin in brain and cerebrospinal fluid in Alzheimer's disease. Int Psychogeriatr 1997;9 Suppl 1:289-96; discussion 317-21.
21. Simonsen AH, McGuire J, Hansson O, Zetterberg H, Podust VN, Davies HA, et al. Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment. Arch Neurol 2007;64:366-70. (Pubitemid 46425690)
22. Steinacker P, Rist W, Swiatek-de-Lange M, Lehnert S, Jesse S, Pabst A, et al. Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease. Proteomics 2010;10:81-9.